EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

From fibro/adipogenic progenitors to adipocytes: Understanding adipogenesis in muscle degeneration for disease modulation

Elisa Villalobos iD, Priyanka Mehra, Jordi Diaz-Manera

The Journal of Physiology · 2025-10 · 603 (19) · 5273-5297

DOI: 10.1113/jp288924 ↗

At a glance

Übersichtsarbeit in The Journal of Physiology, published online on 2025-08-22. Written by Elisa Villalobos and 2 co-authors. Institution: John Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK. Major MEDLINE topics: Adipogenesis, Adipocytes, Stem Cells, Muscle, Skeletal. Cited 10 times so far (Crossref); 153 references. The full text is freely available (open access, CC BY 4.0). Funded by: UKRI | Medical Research Council (MRC), Academy of Medical Sciences (The Academy of Medical Sciences), Society for Endocrinology (SFE).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Fibro/adipogenic progenitors (FAPs) are muscle‐resident stem cells essential for muscle regeneration because of their ability to differentiate into adipocytes and fibroblasts. This differentiation contributes to tissue remodelling and is implicated in the accumulation of fat and fibrotic tissue seen in neuromuscular, cardiovascular and degenerative diseases. FAPs also interact with other muscle cells and modulate inflammation, playing a central role in muscle degeneration across various disease contexts. This review summarises current knowledge on FAP adipogenic differentiation in muscle degeneration and regeneration, with a focus on cardiovascular and neuromuscular diseases, which share common features of impaired muscle remodelling. We discuss established methods for culturing, maintaining, and differentiating FAPs in vitro to support future research. Additionally, we examine FAP subpopulations, key signalling pathways and pharmacological agents influencing FAP differentiation into adipocytes. Understanding these mechanisms offers promising avenues for developing therapeutic strategies to restore muscle homeostasis and slow down pathological muscle remodelling. image

Subjects

MeSH terms (MEDLINE)

AdipogenesisAdipocytesStem CellsMuscle, SkeletalHumansAnimalsCell Differentiation

Author keywords

FAPsadipogenesisfibro/adipogenic progenitorsfibrosismuscleremodelling

Authors and institutions

  • John Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK.
  • Neuromuscular Disease Unit, Departments of Neurology, Hospital de la Santa Creu i Sant Pau, Institut d'Investigacio Biomedica Sant Pau, Barcelona, Spain.

ORCID profiles: Elisa Villalobos

Funding

  • UKRI | Medical Research Council (MRC)
  • Academy of Medical Sciences (The Academy of Medical Sciences)
  • Society for Endocrinology (SFE)
  • French Muscular Dystrophy Association (AFM)

Cite

APA

Villalobos, E., Mehra, P., & Diaz-Manera, J. (2025). From fibro/adipogenic progenitors to adipocytes: Understanding adipogenesis in muscle degeneration for disease modulation. The Journal of Physiology, 603(19), 5273-5297. https://doi.org/10.1113/jp288924

Vancouver

Villalobos E, Mehra P, Diaz-Manera J. From fibro/adipogenic progenitors to adipocytes: Understanding adipogenesis in muscle degeneration for disease modulation. The Journal of Physiology. 2025;603(19):5273-5297. doi:10.1113/jp288924

BibTeX
@article{Villalobos2025,
  author = {Villalobos, Elisa and Mehra, Priyanka and Diaz-Manera, Jordi},
  title = {From fibro/adipogenic progenitors to adipocytes: Understanding adipogenesis in muscle degeneration for disease modulation},
  journal = {The Journal of Physiology},
  year = {2025},
  volume = {603},
  number = {19},
  pages = {5273--5297},
  doi = {10.1113/jp288924}
}
Start for free →